CRISPR gene therapy appears safe, but claims of an imminent HIV cure are premature
From aidsmap.com: A CRISPR-based gene-editing therapy known as EBT-101 was not associated with serious adverse effects in the first three treated study participants, researchers reported last week at the European Society for Gene & Cell Therapy annual meeting in Brussels. The presentation, however, was devoid of any data about whether the treatment works to control…